RB1 and Merkel cell skin cancer: Unlike PRB, research demonstrated that in MCPyV-positive MCCs, LT is not proven to bind to p53 [99], hence reinforcing the hypothesis that either MCPyV Small T antigen (ST) or structural remodeling of the genome of the MCC cell caused by MCPyV itself could affect the activity of p53.